medigraphic.com
ISSN 1561-2988 (Print)

2014, Number 4

<< Back Next >>

Rev Cubana Farm 2014; 48 (4)

Coating of chitosan-Ibuprofen microspheres with a pH-depending interpolymer complex

García CJ, Bada RN, López HOD, Nogueira MA, Caracciolo PC, Abraham GA, Ramón HJÁ, Peniche CC

Language: Spanish
References: 26
Page: 646-657
PDF size: 438.08 Kb.


ABSTRACT

Introduction: the irritating effect on the gastric mucosa caused by non-steroidal anti-inflammatory drugs is one of the main adverse reactions. Their encapsulation in polymer matrices with enteric properties is a technological alternative to solve the problem.
Objective: to obtain ibuprofen-loaded chitosan microparticles coated with a pH dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2- pyrrolidone).
Methods: Ibuprofen-loaded chitosan microparticles were prepared through the spray drying technique; the yield and the efficiency of encapsulation were evaluated. Microparticles were coated with a pH-dependent interpolymer complex based on poly(acrylic acid)/poly(N-vinyl-2-pyrrolidone) using the emulsion/solvent evaporation technique. The complex formation was verified by Fourier transform infrared spectroscopy and the morphological evaluation was made with the electronic scanning microscopy. Release studies used simulated gastric (SGF, pH= 1.2) and intestinal (SIF, pH= 6.8) fluids.
Results: in the process of obtaining the chitosan and chitosan-ibuprofen microparticles, the yield rates amounted to 69 ± 1 % and 54.4 ± 0.8 % respectively were obtained. The encapsulation efficiency was 46.8 ± 0.7 %. The coated microparticles presented rough surface. Complex formation was confirmed by changes in the position of the absorption bands of the functional groups involved in hydrogen bonding. The release of ibuprofen from uncoated microparticles in simulated gastrointestinal fluid reached 40 % whereas it was neglectable in the coated microparticles during the study interval.
Conclusions: the results show the potential of poly(acrylic acid)/poly(N-vinyl-2- pyrrolidone) interpolymer complex as pH dependent cover for use as enteric coating to reduce the side effects on the gastric mucosa of medications such as nonsteroidal anti-inflammatory drugs.


REFERENCES

  1. Madhavan J, Grieser F, Ashokkumar M. Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. J Hazardous Materials. 2010;178:202-8.

  2. Nagpal M, Maheshwari D, Rakha P, Dureja H, Goyal S, Dhingra G. Formulation Development and Evaluation of Alginate Microspheres of Ibuprofen. J Young Pharm. 2012;4(1):13-6.

  3. Dian L, Yang Z, Li F, Wang Z, Pan X, Peng X, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Intern J Nanomed. 2013;8:845-54.

  4. Alonso MJ, Remuñan C. Microencapsulación de medicamentos. In: Vila-Jato JL, editor. Tecnología Farmacéutica Aspectos fundamentales de los sistemas farmacéuticos y operaciones básicas. II. Madrid: Sintesis S.A.; 1997. p. 577-609.

  5. Ding X, Alani AWG, Robinson JR. Extended-release and targeted drug delivery system. In: Troy DB, editor. The Sicence and Practice of Pharmacy. 21th ed. USA: Remington, Lippincott Williams & Wilkins; 2002. p. 939-64.

  6. Tran VT, Benoît JP, Venier-Julienne MC. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Interna J Pharm. 2011;407:1-11.

  7. Tewes F, Boury F, Benoit JP. Biodegradable Microspheres: Advances in Production Technology. In: Benita S, editor. Microencapsulation Methods and Industrial Applications 158. 2nd ed. USA: Taylor & Francis Group; 2006. p. 1-53.

  8. Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Advanced Drug Delivery Reviews. 2010;62:83-99.

  9. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan-a versatile semi-synthetic Polymer in biomedical applications. Progress in Polymer Science. 2011;36(8):981-1014.

  10. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Polymer blends for controlled release coatings. J Control Release. 2008;125:1-15.

  11. Martinac A, Filipovic-Grcic J, Voinovich D, Perissutti B, Franceschinis E. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Intern J Pharm. 2005;291:69-77.

  12. Paños I, Acosta N, Heras A. New Drug Delivery Systems Based on Chitosan. Current Drug Discovery Technol. 2008;5:333-41.

  13. Ganza-Gonzalez A, Anguiano-Igea S, Otero-Espinar FJ, Méndez JB. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide. Eur J Pharm Biopharm. 1999;48:149-55.

  14. Desai KGH, Park HJ. Preparation and Characterization of Drug-Loaded Chitosan- Tripolyphosphate Microspheres by Spray Drying. Drug Development Research. 2005;64:114-28.

  15. Anal AK, Stevens WF, Remuñan-López C. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Intern J Pharm. 2006;312:166-73.

  16. Pavanetto F, Conti B, Genta I, Giunchedi P. Solvent evaporation, solvent extraction and spray-drying for polylactide microsphere preparation. Intern J Pharm. 1992;84:151-9.

  17. Giunchedi P, Gavini E, Bonacucina G, Palmieri GF. Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method. J Microencapsul. 2000;17:711-20.

  18. Peniche C, Fernández M, Gallardo A, López-Bravo A, Román JS. Drug Delivery Systems Based on Porous Chitosan/Polyacrylic acid Microspheres. Macromolec Bioscien. 2003;3:540-5.

  19. Lau C, Mi Y. A study of blending and complexation of poly(acrylic acid)/poly(vinyl pyrrolidone). Polymer. 2002;43:823-9.

  20. Jin S, Liu M, Zhang F, Chen S, Niu A. Synthesis and characterization of pH-sensitivity semi-IPN hydrogel based on hydrogen bond between poly (N-vinylpyrrolidone) and poly(acrylic acid). Polymer. 2006;47:1526-32.

  21. Jin S, Liu M, Chen S, Gao C. A drug-loaded gel based on polyelectrolyte complexes of poly (acrylic acid) with poly (vinylpyrrolidone) and chitosan. Materials Chemistry Physics. 2010;123:463-70.

  22. Jiang B, Hu L, Gao C, Shen J. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties. Intern J Pharmaceutics. 2005;304:220-30.

  23. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus. International Journal of Pharm. 2005;290:145-54.

  24. Arida AI, Al-Tabakha MM. Encapsulation of ketoprofen for controlled drug release. Eur J Pharm Biopharm. 2007;66:48-54.

  25. The United States Pharmacopeia, USP 30. The National Formulary, NF 25 (USP30-NF25). The dissolution procedure: development and validation. Rockville: Mack Printing; 2007.

  26. The United States Pharmacopeia, USP 30. The National Formulary, NF 25 (USP30-NF25). Bisacodyl Delayed-Release Tablets. Rockville: Mack Printing; 2007.




2020     |     www.medigraphic.com